{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:59:45Z","timestamp":1777622385227,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,5,5]],"date-time":"2013-05-05T00:00:00Z","timestamp":1367712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00404-013-2826-8","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T07:39:30Z","timestamp":1367653170000},"page":"1115-1123","source":"Crossref","is-referenced-by-count":49,"title":["A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women"],"prefix":"10.1007","volume":"288","author":[{"given":"Bo-er","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-lan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-xia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-zhu","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-yu","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,5]]},"reference":[{"key":"2826_CR1","first-page":"417","volume":"64","author":"DG Gallup","year":"1984","unstructured":"Gallup DG, Stock RJ (1984) Adenocarcinoma of the endometrium in women 40\u00a0years of age or younger. Obstet Gynecol 64:417\u2013420","journal-title":"Obstet Gynecol"},{"key":"2826_CR2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/PL00008473","volume":"126","author":"G Emons","year":"2000","unstructured":"Emons G, Heyl W (2000) Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol 126:619\u2013623","journal-title":"J Cancer Res Clin Oncol"},{"key":"2826_CR3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/IGC.0b013e3181e94f5a","volume":"20","author":"S Erkanli","year":"2010","unstructured":"Erkanli S, Ayhan A (2010) Fertility-sparing therapy in young women with endometrial cancer: 2010 update. Int J Gynecol Cancer 20:1170\u20131187","journal-title":"Int J Gynecol Cancer"},{"key":"2826_CR4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1471-0528.2008.02024.x","volume":"116","author":"M Signorelli","year":"2009","unstructured":"Signorelli M, Caspani G, Bonazzi C et al (2009) Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases. BJOG 116:114\u2013118","journal-title":"BJOG"},{"key":"2826_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000209324","volume":"67","author":"S Tangjitgamol","year":"2009","unstructured":"Tangjitgamol S, Manusirivithaya S, Hanprasertpong J (2009) Fertility-sparing in endometrial cancer. Gynecol Obstet Invest 67:250\u2013268","journal-title":"Gynecol Obstet Invest"},{"key":"2826_CR6","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ygyno.2008.07.056","volume":"111","author":"L Chiva","year":"2008","unstructured":"Chiva L, Lapuente F, Gonzalez-Cortijo L et al (2008) Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 111:S101\u2013S104","journal-title":"Gynecol Oncol"},{"key":"2826_CR7","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","volume":"25","author":"K Ushijima","year":"2007","unstructured":"Ushijima K, Yahata H, Yoshikawa H et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798\u20132803","journal-title":"J Clin Oncol"},{"key":"2826_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","volume":"95","author":"PT Ramirez","year":"2004","unstructured":"Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C (2004) Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95:133\u2013138","journal-title":"Gynecol Oncol"},{"key":"2826_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3802\/jgo.2012.23.2.120","volume":"23","author":"JP Kesterson","year":"2012","unstructured":"Kesterson JP, Fanning J (2012) Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls. J Gynecol Oncol 23:120\u2013124","journal-title":"J Gynecol Oncol"},{"key":"2826_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","volume":"125","author":"CC Gunderson","year":"2012","unstructured":"Gunderson CC, Fader AN, Carson KA, Bristow RE (2012) Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: a systematic review. Gynecol Oncol 125:477\u2013482","journal-title":"Gynecol Oncol"},{"key":"2826_CR11","first-page":"3047","volume":"31","author":"M Koskas","year":"2011","unstructured":"Koskas M, Yazbeck C, Walker F et al (2011) Fertility-sparing management of grade 2 and 3 endometrial adenocarcinomas. Anticancer Res 31:3047\u20133049","journal-title":"Anticancer Res"},{"key":"2826_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.10.004","volume":"120","author":"G Laurelli","year":"2011","unstructured":"Laurelli G, Di Vagno G, Scaffa C et al (2011) Conservative treatment of early endometrial cancer: preliminary results of a pilot study. Gynecol Oncol 120:43\u201346","journal-title":"Gynecol Oncol"},{"key":"2826_CR13","first-page":"673","volume":"21","author":"MK Kim","year":"2011","unstructured":"Kim MK, Yoon BS, Park H et al (2011) Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study. Int J Gynecol Cancer 21:673\u2013677","journal-title":"Int J Gynecol Cancer"},{"key":"2826_CR14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","volume":"22","author":"L Minig","year":"2011","unstructured":"Minig L, Franchi D, Boveri S et al (2011) Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol 22:643\u2013649","journal-title":"Ann Oncol"},{"key":"2826_CR15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3892\/ol.2012.602","volume":"3","author":"H Fujiwara","year":"2012","unstructured":"Fujiwara H, Jobo T, Takei Y et al (2012) Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma. Oncol Lett 3:1002\u20131006","journal-title":"Oncol Lett"},{"key":"2826_CR16","first-page":"1037","volume":"32","author":"M Koskas","year":"2012","unstructured":"Koskas M, Azria E, Walker F et al (2012) Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility. Anticancer Res 32:1037\u20131043","journal-title":"Anticancer Res"},{"key":"2826_CR17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.11.004","volume":"124","author":"KR Penner","year":"2012","unstructured":"Penner KR, Dorigo O, Aoyama C et al (2012) Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy. Gynecol Oncol 124:542\u2013548","journal-title":"Gynecol Oncol"},{"key":"2826_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijgo.2012.06.010","volume":"119","author":"P Dursun","year":"2012","unstructured":"Dursun P, Erkanli S, Guzel AB et al (2012) A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer. Int J Gynaecol Obstet 119:270\u2013273","journal-title":"Int J Gynaecol Obstet"},{"key":"2826_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00404-011-1959-x","volume":"285","author":"H Park","year":"2012","unstructured":"Park H, Seok JM, Yoon BS et al (2012) Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. Arch Gynecol Obstet 285:473\u2013478","journal-title":"Arch Gynecol Obstet"},{"key":"2826_CR20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","volume":"49","author":"JY Park","year":"2013","unstructured":"Park JY, Kim DY, Kim JH et al (2013) Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer 49:868\u2013874","journal-title":"Eur J Cancer"},{"key":"2826_CR21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/humrep\/dem088","volume":"22","author":"K Yamazawa","year":"2007","unstructured":"Yamazawa K, Hirai M, Fujito A et al (2007) Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod 22:1953\u20131958","journal-title":"Hum Reprod"},{"key":"2826_CR22","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cncr.10435","volume":"94","author":"CB Wang","year":"2002","unstructured":"Wang CB, Wang CJ, Huang HJ et al (2002) Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 94:2192\u20132198","journal-title":"Cancer"},{"key":"2826_CR23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","volume":"17","author":"JT Thigpen","year":"1999","unstructured":"Thigpen JT, Brady MF, Alvarez RD et al (1999) Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17:1736\u20131744","journal-title":"J Clin Oncol"},{"key":"2826_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0360-3016(89)90365-9","volume":"17","author":"SS Ingram","year":"1989","unstructured":"Ingram SS, Rosenman J, Heath R et al (1989) The predictive value of progesterone receptor levels in endometrial cancer. Int J Radiat Oncol Biol Phys 17:21\u201327","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2826_CR25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9378(88)90075-0","volume":"158","author":"CE Ehrlich","year":"1988","unstructured":"Ehrlich CE, Young PC, Stehman FB, Sutton GP, Alford WM (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158:796\u2013807","journal-title":"Am J Obstet Gynecol"},{"key":"2826_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/IGC.0b013e31819c5372","volume":"19","author":"Z Eftekhar","year":"2009","unstructured":"Eftekhar Z, Izadi-Mood N, Yarandi F et al (2009) Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients. Int J Gynecol Cancer 19:249\u2013252","journal-title":"Int J Gynecol Cancer"},{"key":"2826_CR27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fertnstert.2008.12.009","volume":"93","author":"I Mazzon","year":"2010","unstructured":"Mazzon I, Corrado G, Masciullo V et al (2010) Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 93:1286\u20131289","journal-title":"Fertil Steril"},{"key":"2826_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio FJ (2009) Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 30:1\u201350","journal-title":"Endocr Rev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2826-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-013-2826-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2826-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T11:40:39Z","timestamp":1563018039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-013-2826-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2826"],"URL":"https:\/\/doi.org\/10.1007\/s00404-013-2826-8","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,5]]}}}